Using RWE to Make Cost Decisions: A New Report
A recent article, published in JMCP (the Journal of Managed Care and Specialty Pharmacy), considers how RWE (real world evidence) can be utilized when making economic decisions. ICER (the Institute for Clinical and Economic Review) has incorporated RWE in making its recommendations, but few other organizations have been as ready to make such a move.
Payer Engagement Summit Videos on RWD Now Available
ISPOR held its first Payer Engagement Summit in 2020 to discuss the issues facing payers worldwide. The Summit featured discussions [...]
COVID-19 CARE Registry Provides Informative Data
Dr. Nancy Dreyer is the Chief Scientific Officer of IQVIA Real World Solutions. In a recent interview led by Dr. [...]
Syapse Invests $68 Million in Expanding RWE to Improve Outcomes for Cancer Patients
Leading RWE (real world evidence) company Syapse has invested $68 million in a venture with Ally Bridge Group and Northpond [...]
Telehealth Brings Change to Traditional Clinical Visit—and Billing
The start of the COVID-19 pandemic brought many changes to the conventional doctor’s visit. A report by McKinsey found that [...]
What Does the FDA Think About RWE?
A year into the COVID-19 pandemic, the use of RWE in clinical study design is becoming more widespread. In a [...]
As Pandemic Slows, Will Pfizer Increase Vaccine Price?
Pfizer is charging the United States $19.50 per dose of its new vaccine to prevent COVID-19. Pfizer CFO Frank D’Amelio [...]
Upcoming Webinar on COVID-19 Therapeutics and Vaccines
An upcoming webinar will review the data behind treatments for COVID-19, as well as vaccines that have received FDA emergency [...]
Good News: RWE Shows Effectiveness of COVID-19 Vaccines
A recent study examines how the vaccines produced by Moderna and Pfizer might protect against COVID-19. RWE (real world evidence) [...]
Importing Prescription Drugs: What Does Biden Think?
According to former President Trump and current President Biden, Americans should be able to buy prescription drugs from other countries. [...]
A Conversation With Ge Bai Regarding Amazon’s Pharmacy Foray
In a recent podcast with Dr. Ge Bai of Johns Hopkins, important points are discussed relating to Amazon’s venture into [...]
Do Hospitals Actually Mark Up Medications 250%?
A recent report examines the cost differences regarding medications in hospitals. A comparison across two dozen drugs led to the [...]
HealthEconomics.Com’s Value and Evidence Marketplace Seeking Organizations With EHR Data
The Value and Evidence Marketplace is an online tool that matches biomedical and biopharmaceutical researchers with suppliers for research. 24 [...]
Report on Impact of COVID-19 on Global Bioinformatics Market
A recent report discusses how COVID-19 affected the Bioinformatics Market. The impacts on five currencies (USD, EUR, AUD, GBP, JPY) [...]
Prediction Models for COVID-19 Can’t Account for All Human Elements
Early in the COVID-19 pandemic, researchers were scrambling to predict how the disease would spread. One such model was developed [...]
Amalgam Rx, Inc. Acquires Avhana Health
Amalgam Rx. Inc. has acquired Avhana Health, a clinical decision support company with experience in electronic health records. This move [...]
Meta-Analysis Study on Kidney Cancer Utilizes Novel Techniques to Identify Biomarkers
The survival rates of patients with kidney cancer largely depend on identifying biomarkers. The identification of these biomarkers can help [...]
Caesarean Section Procedure Can Vary in Price From 6k to 60k—At the Same Hospital
Women who undergo a caesarean section at the Van Ness site of the Pacific Medical Center in California might be [...]
Webinar: Reflections on Healthcare in 2020 and Visions for 2021
In a recent webinar, the authors discuss important changes and developments in 2020 regarding healthcare regulations. The fast pace of [...]
Webinar on RWE and Progress During COVID-19 Pandemic
The COVID-19 Pandemic has driven many researchers to incorporate RWE (real world evidence) into clinical trials. However, it can often [...]
Using Bayesian Methods in Control Arms of Clinical Trials
The use of single arm trials has become more widespread, especially as the COVID-19 has forced clinical trials to change [...]
New Report Details How SDOH Impact Access to Prescription Drugs
In a recent report, CoverMyMeds discusses how SDOH (social determinants of health) are associated with many patients being forced to [...]
6 Recommendations Regarding HTAs in the United States
A whitepaper was recently released by researchers at the USC Schaeffer Center and the Aspen Institute. The authors discuss half [...]
A Conversation with Peter Pitts on Drug Pricing and Medicare
In a recent podcast by Patients Rising Podcast, the hosts spoke with Peter Pitts. He co-founded and is currently president [...]
Outcry Over Nick Jonas in Super Bowl Commercial for Dexcom
Type 1 Diabetics typically check their blood glucose levels by pricking their finger with a needle to obtain a small [...]